Literature DB >> 20452487

Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle.

Ruben J Kuon1, Shao-Qing Shi, Holger Maul, Christof Sohn, James Balducci, William L Maner, Robert E Garfield.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate cervical changes and delivery at term during pregnancy in rats after various progestin treatments. STUDY
DESIGN: Pregnant rats were treated by various routes and vehicles with progesterone, 17-alpha-hydroxyprogesterone caproate (17P), R5020, and RU-486. Delivery time was determined and cervical ripening was assessed in vivo by collagen light-induced fluorescence.
RESULTS: The cervix is rigid in the progesterone injection, 17P, and vaginal R5020 groups vs controls. Vaginal progesterone had no effect. RU-486 treatment softened the cervix during preterm delivery. Only subcutaneous injected progesterone, R5020 (subcutaneous and vaginal), and topical progesterone in sesame and fish oil inhibits delivery. Delivery is not changed by subcutaneous injection of 17P, vaginal progesterone, oral progesterone, and topical progesterone in Replens (Crinone; Columbia Labs, Livingston, NJ).
CONCLUSION: Inhibition of cervical ripening and delivery by progestins depends on many factors that include their properties, the route of administration, and the vehicle. This study suggests reasons that the present treatments for preterm labor are not efficacious. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452487      PMCID: PMC3048062          DOI: 10.1016/j.ajog.2010.03.025

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  49 in total

1.  Changes in light-induced fluorescence of cervical collagen in guinea pigs during gestation and after sodium nitroprusside treatment.

Authors:  C T Fittkow; S Q Shi; E Bytautiene; G Olson; G R Saade; R E Garfield
Journal:  J Perinat Med       Date:  2001       Impact factor: 1.901

2.  Placement of the vaginal 17beta-estradiol tablets in the inner or outer one third of the vagina affects the preferential delivery of 17beta-estradiol toward the uterus or periurethral areas, thereby modifying efficacy and endometrial safety.

Authors:  Ettore Cicinelli; Edoardo Di Naro; Dominique De Ziegler; Maria Matteo; Stella Morgese; Pietro Galantino; Pierre-Alain Brioschi; AndSergio Schonauer
Journal:  Am J Obstet Gynecol       Date:  2003-07       Impact factor: 8.661

3.  Progestogen administration in pregnancy may prevent preterm delivery.

Authors:  M J Keirse
Journal:  Br J Obstet Gynaecol       Date:  1990-02

4.  Studies of cervical ripening in pregnant rats: effects of various treatments.

Authors:  L Shi; S Q Shi; G R Saade; K Chwalisz; R E Garfield
Journal:  Mol Hum Reprod       Date:  2000-04       Impact factor: 4.025

5.  Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study.

Authors:  Eduardo B da Fonseca; Roberto E Bittar; Mario H B Carvalho; Marcelo Zugaib
Journal:  Am J Obstet Gynecol       Date:  2003-02       Impact factor: 8.661

6.  Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions.

Authors:  Nicole K Ruddock; Shao-Qing Shi; Sangeeta Jain; Gradie Moore; Gary D V Hankins; Roberto Romero; Robert E Garfield
Journal:  Am J Obstet Gynecol       Date:  2008-10       Impact factor: 8.661

7.  The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time.

Authors:  Celeste P Durnwald; Courtney D Lynch; Hetty Walker; Jay D Iams
Journal:  Am J Obstet Gynecol       Date:  2009-08-28       Impact factor: 8.661

8.  Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birth.

Authors:  Steven M Yellon; Charlotte A Ebner; Michal A Elovitz
Journal:  Reprod Sci       Date:  2008-12-15       Impact factor: 3.060

9.  Ripening of the human uterine cervix related to changes in collagen, glycosaminoglycans, and collagenolytic activity.

Authors:  N Uldbjerg; G Ekman; A Malmström; K Olsson; U Ulmsten
Journal:  Am J Obstet Gynecol       Date:  1983-11-15       Impact factor: 8.661

Review 10.  Myometrial progesterone responsiveness and the control of human parturition.

Authors:  Sam Mesiano
Journal:  J Soc Gynecol Investig       Date:  2004-05
View more
  26 in total

1.  A novel optical method to assess cervical changes during pregnancy and use to evaluate the effects of progestins on term and preterm labor.

Authors:  Ruben J Kuon; Shao-Qing Shi; Holger Maul; Christof Sohn; James Balducci; Leili Shi; Robert E Garfield
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

Review 2.  17 α-Hydroxyprogesterone caproate (Makena™): in the prevention of preterm birth.

Authors:  Emma D Deeks
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

Review 3.  Progestin treatment for the prevention of preterm birth.

Authors:  Miha Lucovnik; Ruben J Kuon; Linda R Chambliss; William L Maner; Shao-Qing Shi; Leili Shi; James Balducci; Robert E Garfield
Journal:  Acta Obstet Gynecol Scand       Date:  2011-06-27       Impact factor: 3.636

4.  Progesterone supplementation and the prevention of preterm birth.

Authors:  Errol R Norwitz; Aaron B Caughey
Journal:  Rev Obstet Gynecol       Date:  2011

Review 5.  Beyond cervical length: emerging technologies for assessing the pregnant cervix.

Authors:  Helen Feltovich; Timothy J Hall; Vincenzo Berghella
Journal:  Am J Obstet Gynecol       Date:  2012-05-23       Impact factor: 8.661

6.  Transection of the pelvic or vagus nerve forestalls ripening of the cervix and delays birth in rats.

Authors:  Lindsey A Clyde; Thomas J Lechuga; Charlotte A Ebner; Alexandra E Burns; Michael A Kirby; Steven M Yellon
Journal:  Biol Reprod       Date:  2010-11-24       Impact factor: 4.285

7.  Inhibitory effect of progesterone on cervical tissue formation in a three-dimensional culture system with human cervical fibroblasts.

Authors:  Michael House; Serkalem Tadesse-Telila; Errol R Norwitz; Simona Socrate; David L Kaplan
Journal:  Biol Reprod       Date:  2014-01-30       Impact factor: 4.285

Review 8.  Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Kypros Nicolaides; Tinnakorn Chaiworapongsa; John M O'Brien; Elcin Cetingoz; Eduardo da Fonseca; George Creasy; Priya Soma-Pillay; Shalini Fusey; Cetin Cam; Zarko Alfirevic; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2012-11-15       Impact factor: 8.661

9.  Vaginal progesterone, but not 17α-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface.

Authors:  Amy-Eunice Furcron; Roberto Romero; Olesya Plazyo; Ronald Unkel; Yi Xu; Sonia S Hassan; Piya Chaemsaithong; Arushi Mahajan; Nardhy Gomez-Lopez
Journal:  Am J Obstet Gynecol       Date:  2015-08-08       Impact factor: 8.661

10.  Agonist-Dependent Downregulation of Progesterone Receptors in Human Cervical Stromal Fibroblasts.

Authors:  William E Ackerman; Taryn L Summerfield; Sam Mesiano; Frederick Schatz; Charles J Lockwood; Douglas A Kniss
Journal:  Reprod Sci       Date:  2015-08-04       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.